Integra LifeSciences shares gapped up, short interest declined, and analysts downgraded the stock in April.

Integra LifeSciences (NASDAQ:IART) shares gapped up to $27.49 before trading on Friday. Short interest in the company declined by 6.1% in April, with 2,450,000 shares shorted as of April 30th, down from 2,610,000 shares on April 15th. Analysts have recently weighed in on the stock, with StockNews.com downgrading it from a "buy" to a "hold" rating, while Wells Fargo & Company downgraded it from "overweight" to "equal weight" and Morgan Stanley cut its price objective from $37 to $24.